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Abstract
Background: Skin autofluorescence (SAF), which is a measure of accumula-
tion of advanced glycation end-products (AGE), and malnutrition are each
associated with higher mortality in dialysis populations, although no studies
have investigated these potentially related associations together. We simulta-
neously assessed SAF and malnutrition as risk factors for mortality in per-
sons receiving dialysis.
Methods: SAF was measured in 120 haemodialysis and 31 peritoneal dialysis
patients using an AGE Reader (DiagnOptics, Groningen, The Netherlands).
Dietary AGE, energy, protein and fat intake, handgrip strength, anthropom-
etry, biochemistry and Subjective Global Assessment were also evaluated.
Time to event was days from baseline to death, kidney transplantation or 30
September 2018.
Results: Median observation time was 576 days, during which 33 (21.9%)
patients died. Those who died had higher baseline SAF levels [3.8  1.0 ver-
sus 3.3  0.8 arbitrary units (AU); P = 0.001] and were more likely to be
malnourished (58% versus 31%; P = 0.006). Malnourished persons who
died had higher SAF values than those who died but were well-nourished
(4.2  1.1 versus 3.3  0.7 AU; P = 0.007). Survival was significantly better
in participants with baseline SAF below the median and in those well-nour-
ished than those with baseline SAF above the median and in those malnour-
ished, respectively. Multivariable analysis identified SAF [hazards ratio
(HR) = 1.44; 95% confidence interval (CI) = 1.05–1.97; P = 0.02], malnu-
trition (HR = 2.35; 95% CI = 1.16–4.78; P = 0.02) and chronological age
(HR = 1.60; 95% CI = 1.10–2.33; P = 0.01) as independent predictors of
mortality.
Conclusions: Although higher SAF and malnutrition are potentially inter-
related, they were both independently associated with increased mortality in
this population. Interventions to improve outcomes by reducing SAF
through correction of malnutrition or dietary AGE restriction require test-
ing in prospective studies.
Introduction
Dialysis is a life-prolonging therapy for persons with end-
stage kidney disease (ESKD), although it is associated
with a high mortality rate in large part due to increased
cardiovascular disease (1,2). Malnutrition, systemic inflam-
mation and oxidative stress have been proposed as non-
traditional cardiovascular risk factors that contribute to
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the increased cardiovascular mortality risk observed in
the ESKD population (3), although the manner in which
these factors interact and their relative importance
remains to be elucidated.
Advanced glycation end-products (AGEs) are uremic
toxins that accumulate in persons receiving dialysis as a
result of reduced renal clearance and increased formation
(4,5). Endogenous sources of AGEs include oxidative and
carbonyl stress, as well as hyperglycaemia (4). AGEs can
also be formed exogenously, either by cigarette smoking
or through the ingestion of foods cooked under dry heat
and high temperatures (e.g. grilling, roasting, frying) (6).
Taking advantage of the fluorescence properties of some
AGEs, the accumulation of these toxins in the skin can be
assessed non-invasively using skin autofluorescence
(SAF), which has proven to be an independent predictor
of all-cause and cardiovascular mortality in the dialysis
population (7–9); however, the mechanisms underlying
this association are not completely understood.
AGEs are markers of oxidative stress, which is linked
with systemic inflammation. Oxidative and inflammatory
processes act synergistically with respect to promoting
protein catabolism, muscle wasting and reduced hepatic
albumin synthesis, which together lead to the develop-
ment of malnutrition in the setting of ESKD (10,11). Mal-
nutrition, an independent predictor of mortality in the
dialysis population (12–15), exacerbates the deleterious
effects of systemic inflammation and oxidative stress by
increasing the susceptibility to infections and cardiovascu-
lar disease risk (16,17). It therefore appears reasonable to
suggest that a vicious cycle between inflammation, oxida-
tive stress and malnutrition may contribute to the poor
survival rates observed in persons on dialysis (18). Malnu-
trition and SAF have previously been reported in separate
studies to independently predict worse survival on dialysis
but, to our knowledge, no studies have simultaneously
investigated the association of SAF and malnutrition with
mortality. This is particularly important because it has
been previously reported that higher SAF and several
markers of malnutrition are independently associated in
persons on haemodialysis (HD) (19), raising the possibility
that the association between higher SAF and poorer sur-
vival may be explained by an association with malnutri-
tion, which was not assessed in previous studies (7,9). We
therefore aimed to investigate the prognostic significance




This was a single centre prospective observational study
conducted in the Department of Renal Medicine, Royal
Derby Hospital. Persons receiving HD and performing
peritoneal dialysis (PD) who were ≥18 years of age and
had an expected survival more than 1 year were eligible.
We enrolled 120 HD and 31 PD patients from September
2016 to August 2017. Participants on HD were dialysed
three or four times per week for 3–4 h using high-flux
polysulphone, polyarylethersulfone or polyvinylpyrroli-
done dialyzers. Persons performing PD dialysed using lac-
tate/bicarbonate-buffered 1.36% and 3.86% glucose
(Physioneal; Baxter Healthcare Corporation, Deerfield, IL,
USA), 7.5% icodextrin (Extraneal; Baxter Healthcare Cor-
poration) and/or 1.1% aminoacid-containing solutions
(Nutrineal; Baxter Healthcare Corporation). The exclu-
sion criteria used were: pregnancy or intending preg-
nancy, breastfeeding and having dark skin colour.
Written informed consent was obtained from all patients.
The study was approved by the local Research Ethics
Committee (East Midlands – Nottingham 1. REC refer-
ence: 16/EM/0243).
Data collection
Electronic medical records were used to collect participant
characteristics, including: age, sex, ethnicity, dialysis vin-
tage (i.e. time subsequent to first dialysis treatment), dial-
ysis adequacy, blood results, presence of diabetes (defined
by clinical diagnosis) and obesity [defined as having a
body mass index (BMI), ≥30 kg m2] (20), as well as his-
tory of cardiovascular disease. Information regarding edu-
cational level, occupation and smoking status was
obtained from direct interview.
Dates and causes of death were obtained from elec-
tronic medical records. Causes of death were classified
into specific groups (21): cardiovascular, infection, malig-
nancy, treatment withdrawal and other cause of death.
The classification was performed independently by two
consultant nephrologists (NMS and MWT) and any dis-
agreements were resolved by discussion. Survival time was
defined as the number of days between the baseline
assessment and the date of death, censoring as a result of
kidney transplantation or 30 September 2018.
Skin autofluorescence measurement
SAF was measured using a validated Autofluorescence
Reader, version 2.4.3 (AGE Reader; DiagnOptics, Gronin-
gen, The Netherlands) as described in more detail else-
where (7,19). In brief, the AGE Reader directs an ultraviolet
excitation light (intensity 300–420 nm) through an illumi-
nation window of approximately 1 cm2 on a skin area (free
of visible vessels, scars, tattoos or any other skin irregulari-
ties) of the volar surface of the forearm at approximately
10 cm below the elbow. The AGE Reader then measures
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the amount of emitted light that is reflected back from the
skin (intensity 300–600 nm) using a spectrometer (AVS-
USB2000; Avantes Inc., Eerbeek, The Netherlands) and a
200-µm glass fibre. SAF is calculated by dividing the aver-
age emitted light intensity in the range between 420–
600 nm by the average excitation light intensity in the
range between 300–420 nm, and expressed as arbitrary
units (AU). Three SAF readings were conducted on the
nonfistula arm or the dominant arm if this did not have a
fistula, and within the first hour of HD treatment. The
mean value of three SAF readings was used for statistical
analyses. SAF readings may be affected by dark skin colour
and pigmentation as a result of a higher proportion of the
excitation light being absorbed. The AGE Reader has not
yet been validated in persons with darker skin colour and
skin reflectivity <6% (i.e. Fitzpatrick skin colour types 5–6)
(22). Consequently, SAF might not be reliable in this popu-
lation and persons with dark skin were therefore excluded.
It has been previously reported that SAF readings have
good reproducibility and repeatability (i.e. coefficient of
variation of 7–8%) (23).
Nutritional assessments
Information regarding energy, protein and fat intake was
obtained from three 24-h dietary recalls. Participants were
asked to recall all foods and drinks they had the day before.
Dietary recalls were analysed with DIETPLAN, version 7
(Forestfield Software Limited, Broadbridge Heath, UK) to
calculate the average energy, protein and fat intake. Average
daily intake of energy and protein was then calculated (kJ
and g, respectively) and expressed per kg of ideal body
weight. Dietary AGE intake (reported in kilounits per day)
was estimated with a food frequency questionnaire previ-
ously validated in persons with diabetes (24). For further
analysis, dietary AGE intake was corrected for total average
energy intake and for post-dialysis body weight.
Anthropometric measurements were conducted in line
with international standard methods of assessment (25).
Post-dialysis weight and height were measured to calculate
BMI (kg m2), whereas measurement of mid-arm circum-
ference (MAC) and triceps skinfold thickness (TSF) (both
in cm) was conducted to calculate mid-arm muscle cir-
cumference (MAMC) using the equation: MAMC (cm2) =
MAC – (3.14 9 TSF). Handgrip strength (HGS) measure-
ment was conducted within the first hour of HD treatment
or during PD clinic visits using the Takei 5401 handgrip
digital dynamometer (Takei Scientific Instruments Co.,
Ltd, Tokyo, Japan). HGS was measured in the nonfistula
arm or the dominant arm if this did not have a fistula as
described elsewhere (19).
The seven-point scale Subjective Global Assessment
(SGA) (26) was performed to evaluate the nutritional
status. Based on the ratings of six individual core compo-
nents (i.e. history of weight loss, dietary intake, gastroin-
testinal symptoms, functional status, metabolic stress and
subjective physical examination of loss of subcutaneous
fat and muscle mass, and presence of oedema), nutri-
tional status can be classified into normal nutritional sta-
tus (scores of 6 or 7), mild-moderate malnutrition
(scores of 3–5) or severe malnutrition (scores of 1 or 2).
For statistical analysis, participants were placed in two
groups: well-nourished (SGA scores 6–7) or malnourished
(SGA scores 1–5).
Statistical analysis
All statistical analyses were performed using SPSS, version
24.0 (IBM Corp., Armonk, NY, USA). Data are expressed
as the mean (SD), median [interquartile range (IQR)],
percentages or hazard ratios [HR, 95% confidence inter-
val (CI)], as appropriate. Missing data were omitted: C-
reactive protein (CRP), n = 7; HGS, n = 6; MAC, MAMC
and TSF, n = 1. Comparisons of continuous variables
between two independent groups were performed using
Student’s t test or a Mann–Whitney U test, whereas inter-
group comparisons for categorical variables were con-
ducted with a chi-squared test or Fisher’s exact test.
Kaplan–Meier survival curves were computed according
to baseline SAF levels above or below the median value
and nutritional status at baseline.
Cox proportional hazards models were used to investi-
gate the prognostic value of SAF and malnutrition for
predicting mortality. As a result of the limited number of
events (deaths), only the three variables of greatest inter-
est that were associated with mortality in the univariable
analyses were included in the model. A product term (i.e.
two-way interaction term) was included in the regression
model to test for an interaction between SAF and malnu-
trition. P < 0.05 was considered statistically significant.
Sample size determination with mortality as the pri-
mary outcome showed that with a sample size of 150 par-
ticipants split in two groups (group 1: SAF below the
median, n = 75; group 2: SAF above the median,
n = 75), the analysis would have more than 80% power
to detect a HR of 2.7, assuming that the total number of
events (i.e. deaths) achieved was 34 and the average prob-
ability of the event was 0.1 in group 1 and 0.35 in group
2 (NQUERY ADVANCED, version 8.0; Statistical Solutions Lim-
ited, Boston, MA, USA).
RESULTS
Baseline participant characteristics
The demographic, clinical, biochemical and nutritional
characteristics of 120 HD and 31 PD participants are
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shown in Table 1. The mean (SD) age of the whole
cohort was 64 (14) years. Sixty-four percent of the popu-
lation were male and 88% were of white ethnicity. Mean
(SD) SAF was high at 3.4 (0.9) AU compared to the ref-
erence value of 2.5 (0.6) AU for the age group of 60–
70 years (27). Participants had low calorie and protein
intake compared to the estimated nutritional require-
ments for persons receiving dialysis (28).
SGA identified 56 participants (37%) as malnourished
and 95 as well-nourished (63%). SAF was significantly
higher in malnourished participants compared to those
who were well-nourished. Serum albumin, total dietary
AGE, energy, protein and fat intake, HGS, and all anthro-
pometric variables were significantly lower in malnour-
ished participants compared to those with a well-
nourished status. Dietary AGE intake corrected for post-
dialysis body weight and for total energy intake was not
significantly different between malnourished and well-
nourished participants. Females, current smokers and
those who were unemployed were more likely to be mal-
nourished than males, nonsmokers and employed partici-
pants, respectively. Coronary heart disease was more
evident in malnourished participants (Table 1).
Follow-up results
Median observation time was 576 days (IQR = 395–
684 days) during which 33 (21.9%) participants died and
22 (14.6%) received a kidney transplant. The most com-
mon cause of death was infection (33.3%) followed by
cardiovascular (30.3%), treatment withdrawal (15.1%),
other cause of death (12.1%) and cancer (9.2%).
Table 2 shows baseline participant characteristics
according to survival status. Participants who died had
Table 1 Baseline participant characteristics by nutritional status classification
Variable Overall (n = 151) Malnourished (n = 56) Well-nourished (n = 95) P value†
Age (years) 64 (14) 62 (16) 65 (13) 0.5
Female, n (%) 54 (36) 30 (54) 24 (25) <0.0001
White ethnicity, n (%) 133 (88) 47 (84) 86 (91) 0.2
Educational qualifications, n (%) 85 (56) 28 (50) 57 (60) 0.2
Unemployed, n (%) 114 (76) 48 (86) 66 (70) 0.03
Current smoking, n (%) 23 (15) 16 (29) 7 (7) <0.0001
Diabetes, n (%) 62 (41) 21 (38) 41 (43) 0.5
Coronary heart disease, n (%) 60 (40) 29 (52) 31 (33) 0.02
Peripheral vascular disease, n (%) 11 (7) 5 (9) 6 (6) 0.6
Obesity, n (%) 55 (36) 11 (20) 44 (46) 0.001
Dialysis vintage (months) 29 (10–69) 31 (11–61) 26 (10–67) 0.4
Dialysis adequacy (Kt V1)* 1.45 (0.59) 1.54 (0.62) 1.40 (0.56) 0.1
Serum albumin (g L1) 31.5 (4.6) 30.1 (5.4) 32.4 (3.8) 0.02
C reactive protein (mg L1) 8 (4 to 17) 9 (3 to 23) 8 (4 to 14) 0.6
Total cholesterol (mmol L1) 4.1 (1.2) 4.2 (1.3) 4.1 (1.1) 0.9
Serum creatinine (µmol L1) 646 (214) 607 (211) 669 (214) 0.06
Serum phosphate (mmol L1) 1.56 (0.51) 1.64 (0.56) 1.51 (0.47) 0.2
Serum potassium (mmol L1) 4.6 (0.7) 4.5 (0.7) 4.7 (0.7) 0.2
Skin autofluorescence (AU) 3.4 (0.9) 3.6 (1.0) 3.2 (0.7) 0.009
Dietary AGE intake (kU day1) 14545 (781) 12763 (6580) 15595 (8315) 0.02
Dietary AGE intake/body weight (kU kg1) 168 (120–237) 168 (122–237) 168 (115–237) 1.0
Dietary AGE intake/energy intake (kU kJ1) 2.2 (1.7–3.1) 2.3 (1.7–3.4) 2.2 (1.7–3.1) 0.6
Energy intake (kJ kg1 day1)‡ 87.5 (31.8) 77.9 (31.8) 92.9 (30.6) 0.001
Protein intake (g kg1 day1) 0.88 (0.29) 0.79 (0.32) 0.94 (0.25) <0.0001
Fat intake (g day1) 57.9 (29.7) 47.9 (24.2) 63.8 (31.2) <0.0001
Post-dialysis weight (kg) 79.3 (20.8) 69.7 (17.8) 85.0 (20.4) <0.0001
Body mass index (kg m2) 27.7 (6.3) 25.1 (5.1) 29.2 (6.4) <0.0001
Handgrip strength (kg) 23.0 (11.5) 19.1 (10.9) 25.1 (11.3) 0.001
Mid-arm muscle circumference (cm2) 25.6 (3.7) 23.9 (3.6) 26.6 (3.5) <0.0001
Triceps skinfold thickness (mm) 17.2 (7.2) 15.1 (6.3) 18.4 (7.5) 0.02
Data are expressed as the mean (SD), median (interquartile range) or percentages, as appropriate
AGE, advanced glycation end-product; AU, arbitrary units; kU, kilounits.




kcal kg1 day1: overall, 20.9 (7.6); malnourished, 18.6 (7.6); well-nourished, 22.2 (7.3).
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significantly higher baseline SAF and CRP levels com-
pared to those who did not die. Nonsurvivors were more
likely to be malnourished in comparison to survivors.
Participants who died also had significantly lower serum
albumin, HGS, and energy, protein and fat intake com-
pared to those who did not die. Older age, lack of educa-
tional qualifications and unemployment were more
evident among nonsurvivors than in survivors.
Participants who died and were malnourished (n = 19)
had significantly higher SAF levels and lower serum
albumin, serum creatinine, total dietary AGE, energy,
protein and fat intake, BMI, HGS, MAMC, and TSF com-
pared to those who died but were well-nourished
(n = 14) (see Supporting information, Table S1). No sig-
nificant differences were observed in dietary AGE intake
corrected for body weight and for total energy intake
between survivors and nonsurvivors, nor between those
who died and were malnourished and those who died but
were well-nourished.
Kaplan–Meier analysis showed that survival was signifi-
cantly better in those participants with a baseline SAF level
below the median value of 3.3 AU and in those who were
well-nourished at baseline in comparison to those with
baseline SAF level above the median value and in those mal-
nourished at baseline, respectively (Figures 1 and 2). Uni-
variable analysis identified malnutrition, no educational
qualifications, higher SAF, chronological age and lower
serum albumin, HGS, and energy, protein and fat intake as
significant determinants of higher mortality, although total
dietary AGE intake, as well as AGE intake corrected for
body weight and for total energy intake, were not. Multi-
variable Cox proportional hazards analysis identified SAF
(HR = 1.44; 95% CI = 1.05–1.97 per SD; P = 0.02), mal-
nutrition (HR = 2.35; 95% CI = 1.164.78; P = 0.02) and
chronological age (HR = 1.60; 95% CI = 1.10–2.33 per SD;
P = 0.01) as independent predictors of mortality (Table 3).
Inclusion of a product term in the model showed no inter-
action between SAF and malnutrition.
Discussion
In this prospective observational study, we found that
higher SAF and malnutrition were both significant and
independent predictors of increased mortality in persons
receiving dialysis. We also identified that several markers
of malnutrition such as serum albumin, HGS, and energy,
protein and fat intake were important determinants of
higher mortality, and that SAF was significantly increased
among those dialysis patients who died and were mal-
nourished.
The association between SAF and increased mortality
in persons receiving dialysis has been investigated previ-
ously in several studies. In one of the first prospective
studies carried out in this area (7), higher SAF was inde-
pendently associated with a four-fold increased mortality
risk over 3 years, with cardiovascular disease being the
main cause of death. We observed a 44% higher risk of
all-cause mortality for each SD increase in SAF. Similarly,
Mukai et al. (8) reported that each one SD increase in
SAF was independently associated with a 56% higher risk
of death. Several other observational studies have also
reported that increased SAF independently predicts higher
rates of all-cause and cardiovascular mortality in persons









Age (years) 69 (12) 62 (14) 0.004
Female, n (%) 13 (39) 41 (35) 0.6
Educational
qualifications, n (%)
20 (61) 46 (39) 0.03
Unemployed, n (%) 30 (91) 84 (71) 0.02
Current smoking, n (%) 6 (18) 17 (14) 0.6
Diabetes, n (%) 15 (46) 47 (40) 0.6
Coronary heart disease,
n (%)
17 (52) 43 (36) 0.1
Malnutrition, n (%) 19 (58) 37 (31) 0.006
Dialysis vintage
(months)
43 (20–71) 25 (8–68) 0.1
Serum albumin (g L1) 29.5 (6.1) 32.1 (3.9) 0.02
C reactive protein
(mg L1)
11 (5 to 29) 7 (3 to 14) 0.04
Total cholesterol
(mmol L1)
4.0 (1.2) 4.1 (1.2) 0.6
Serum creatinine
(µmol L1)
657 (206) 643 (217) 0.8
Skin autofluorescence
(AU)
3.8 (1.0) 3.3 (0.8) 0.002
Dietary AGE intake
(kU day1)
13381 (7032) 14870 (8019) 0.4
Energy intake
(kJ kg1 day1)†
75.4 (26.0) 90.8 (32.7) 0.01
Protein intake
(g kg1 day1)
0.75 (0.25) 0.92 (0.29) 0.003
Fat intake (g day1) 48.6 (24.7) 60.5 (30.6) 0.02
Body mass index
(kg m2)
28.3 (6.5) 27.5 (6.2) 0.6
Handgrip strength (kg) 18.6 (10.7) 24.1 (11.5) 0.008
Mid-arm muscle
circumference (cm2)
25.7 (4.5) 25.6 (3.5) 0.7
Triceps skinfold
thickness (mm)
18.5 (6.7) 16.9 (7.4) 0.2
Data are expressed as the mean (SD), median (interquartile range) or
percentages, as appropriate.




kcal kg1 day1: non-survivors, 18.0 (6.2); survivors, 21.7 (7.8).
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receiving dialysis (9,29–32). Multiple mechanisms may
explain the association between increased SAF and mor-
tality. AGEs cross-link proteins of the extracellular matrix
(e.g. collagen and elastin), altering their structural and
functional properties, which translates into increased arte-
rial stiffness and endothelial dysfunction (33), both of
which contribute to the pathogenesis of cardiovascular
disease. In addition, AGEs exacerbate vascular tissue dam-
age by binding to specific AGE receptors that induce
oxidative stress and systemic inflammation (34). Systemic
inflammation in turn promotes endothelial dysfunction
and vascular calcification (35). Oxidative stress, alongside
inflammation, also causes endothelial dysfunction, which
leads to the development and progression of atherosclero-
sis (10,36–38). Additionally, the association may be
explained, at least in part, by an association between
increased SAF and malnutrition (19), which is a well-de-
scribed risk factor for reduced survival on dialysis,
although, unfortunately none of the aforementioned
prospective studies included an assessment of nutritional
Figure 1 Kaplan–Meier plot of survival according to baseline skin autofluorescence (SAF) above or below the median value.
Figure 2 Kaplan–Meier plot of survival according to nutritional status at baseline.
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status. We have now filled this knowledge gap by showing
that SAF and malnutrition are independent predictors of
higher mortality on dialysis. Thus, elevated SAF does not
appear to be simply a surrogate marker of malnutrition.
Malnutrition is one of the major and most prevalent
complications in persons receiving dialysis(39,40). In the
present study, we found that malnutrition, as assessed by
the seven-point scale SGA, was a significant and indepen-
dent determinant of increased mortality. Several prospec-
tive studies have also reported that malnutrition, as
evaluated by the original and modified versions of the
SGA, is independently and strongly associated with over-
all and cardiovascular mortality in the dialysis population
(12–15). This association might be partially explained by
interactions between multiple risk factors related to mal-
nutrition that are also associated with increased mortality,
including inadequate dietary intake (41–44), presence of
cardiovascular disease (2), metabolic acidosis (45) and,
most importantly, systemic inflammation (46) and oxida-
tive stress (36). Although the accuracy of the seven-point
scale SGA to assess nutritional status relies on the dieti-
tian’s experience and training to interpret the data col-
lected (40), it continues to be the recommended
nutritional assessment tool by national and international
nutrition guidelines in the dialysis population (28,47).
It has been reported previously in a cross-sectional
analysis that SAF was significantly higher among mal-
nourished persons on HD and that markers of malnutri-
tion such as lower serum albumin, lower protein intake
and lower HGS, as well as longer dialysis vintage, pres-
ence of diabetes and history of smoking, were indepen-
dent determinants of increased SAF (19). The present
study extends these observations by showing that higher
SAF and malnutrition were independent risk factors for
higher mortality, although no interaction was found on
statistical testing. Additionally, SAF was significantly
higher in nonsurvivors who were malnourished compared
to those who died but were well-nourished. Furthermore,
lower serum albumin, HGS, and energy, protein and fat
intake were significant determinants of higher mortality
in univariable analyses. The association between higher
SAF and malnutrition may be explained by overlapping
mechanisms that likely contribute to both. AGEs are
rapidly formed during oxidative stress. Oxidative stress in
turn promotes systemic inflammation and vice versa.
Chronic inflammation and oxidative stress together
induce a number of mechanisms including increased
muscle proteolysis, decreased appetite and hypoalbumine-
mia, which ultimately lead to the development of malnu-
trition (10,11,48). Malnutrition may also contribute to AGE
Table 3 Cox proportional hazards analysis showing predictors of overall mortality in persons receiving dialysis
Predictor
Univariable analysis Multivariable analysis
HR (95% CI) P value HR (95% CI) P value
Age (years) 1.53 (1.04–2.24) 0.03 1.60 (1.10–2.33) 0.01
Sex (Female versus Male) 1.18 (0.59–2.37) 0.7
Educational qualifications (No versus Yes) 2.09 (1.04–4.12) 0.04
Current smoking (Yes versus No) 1.15 (0.48–2.79) 0.8
Diabetes (Yes versus No) 1.12 (0.57–2.23) 0.7
Coronary heart disease (Yes versus No) 1.59 (0.80–3.15) 0.2
Nutritional status (Malnourished versus Well-nourished) 2.30 (1.15–4.59) 0.02 2.35 (1.16–4.78) 0.02
Dialysis vintage (months) 1.00 (0.99–1.00) 0.7
Serum albumin (g L1) 0.89 (0.84–0.96) 0.001
C reactive protein (mg L1) 1.01 (1.00–1.03) 0.06
Total cholesterol (mmol L1) 0.92 (0.67–1.25) 0.6
Serum creatinine (µmol L1) 1.00 (0.99–1.00) 0.6
Skin autofluorescence (AU) 1.55 (1.16–2.07) 0.003 1.44 (1.05–1.97) 0.02
Dietary AGE intake (kU day1) 1.00 (1.00–1.00) 0.4
Dietary AGE intake/body weight (kU kg1) 1.00 (0.99–1.00) 0.2
Dietary AGE intake/energy intake (kU kJ1) 1.01 (0.98–1.06) 0.3
Energy intake (kJ kg1 day1) 0.93 (0.88–0.99) 0.02
Protein intake (g kg1 day1) 0.16 (0.04–0.61) 0.008
Fat intake (g day1) 0.98 (0.97–0.99) 0.03
Body mass index (kg m2) 1.02 (0.97–1.07) 0.5
Handgrip strength (kg) 0.96 (0.92–0.99) 0.04
Mid-arm muscle circumference (cm2) 1.01 (0.92–1.11) 0.8
Triceps skinfold thickness (mm) 1.03 (0.98–1.07) 0.2
AGE, advanced glycation end-product; AU, arbitrary units; CI, confidence interval; kU, kilounits; HR, hazards ratio.
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formation through its interaction with oxidative and
inflammatory processes. Thus, a vicious cycle likely exists
between chronic inflammation, oxidative stress and mal-
nutrition to explain the association between SAF, malnu-
trition and increased mortality.
Our findings highlight the importance of dietetic
monitoring and support to help patients cope with the
nutritional challenges associated with ESKD (39). Malnu-
trition should be detected early by means of comprehen-
sive screening and assessment using different objective
and subjective nutritional markers (40), followed by
implementation of an individualised dietetic intervention
to treat it. One recent proof of principle study has
reported that an improvement of nutritional intake and
markers of nutritional status was associated with the sta-
bilisation of SAF levels in malnourished persons receiv-
ing dialysis (49). On the other hand, restriction of dietary
AGE intake has been found to reduce serum AGE levels
in some patient groups (50,51) but risks provoking or
exacerbating malnutrition in patients requiring dialysis
(19,52) and would therefore require close dietetic supervi-
sion. Large prospective trials are now warranted to inves-
tigate the role of dietary interventions with respect to
reducing SAF and improving outcomes in persons
receiving dialysis.
There are some limitations that need to be considered
when interpreting our findings. First, we included subjects
from a single centre and the sample size was relatively
small, which prevented us from including more variables
in the multivariable Cox proportional hazards model, and
may have resulted in a failure to detect weaker associa-
tions between some baseline variables and outcomes. Sec-
ond, the follow-up period was relatively short, and a
longer observation period may have revealed more evi-
dence of interaction between higher SAF, malnutrition
and mortality. Third, we limited our analysis to consider-
ation of baseline variables, whereas a larger study would
have allowed inclusion of change in SAF and change in
nutritional status as time-varying factors. Nevertheless,
unlike previous cohorts, the present study is the first to
prospectively and simultaneously assess SAF and malnu-
trition as risk factors for increased mortality. The obser-
vational design of the present study did not allow us to
assess causality; however, our results suggest that the risk
of death is considerably higher among those subjects with
increased SAF and malnutrition. Finally, valid SAF read-
ings cannot be obtained when the skin reflectivity is lower
than 6% (22); therefore, persons with dark skin colour
(i.e. Fitzpatrick skin colour types 5–6), who have an
ultraviolet reflectance of less than 6%, were excluded
from the study, and our findings may be applicable only
to persons with Fitzpatrick skin types 1–4.
In conclusion, although higher SAF and malnutrition
are potentially inter-related, we have found that they were
independently associated with increased mortality in this
dialysis population. Our observations strengthen the role
of SAF as an independent risk factor in the dialysis popu-
lation and suggest that interventions to reduce SAF may
result in improved survival, although this should now be
tested in prospective trials. Such interventions may
include correction of malnutrition and dietary AGE
restriction, although care should be taken in the latter
case to avoid exacerbating malnutrition.
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